Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 22
|
ECE2010
|
Next issue
12th European Congress of Endocrinology
All volumes
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Programme
Volume Editors
Abstracts
Contents
Prize Lectures and Biographical Notes
The European Journal of Endocrinology Prize Lecture
Translating bone cell biology into clinical practice: target identified as RANK ligand
ea0022eje1
European Journal of Endocrinology Prize Winner
ea0022eje1biog
The Geoffrey Harris Prize Lecture
Transgenes and physiology in the Growth Hormone axis: a view from the portal
ea0022gh1
Geoffrey Harris Prize Winner
ea0022gh1biog
Plenary Lectures
Twenty years' experience with post-Chernobyl thyroid cancer
Twenty years experience with post-Chernobyl thyroid cancer
ea0022pl1
Testicular dysgenesis and endocrine disruptors
Testicular dysgenesis and endocrine disrupters
ea0022pl2
Hypothalamic regulation of gonadotrophin secretion
Novel regulator of gonadotropin
ea0022pl3
Thyronamines: beyond T
4
and T
3
Thyronamines: beyond T4 and T3
ea0022pl4
Discovery and relevance of the incretin system
Discovery and relevance of the incretin system
ea0022pl5
Sex and SOX
Sex and SOX
ea0022pl6
New trends in diagnosis and localisation of (neuro) endocrine tumours
New trends in diagnosis and localization of (neuro)endocrine tumors
ea0022pl7
An update on the genetics of obesity
An update on the genetics of obesity
ea0022pl8
Symposia
European networks
Endocrinology of the aging male: the European Male Ageing Study (EMAS)
ea0022s1.1
NECTAR: network for environmental chemical toxicants affecting reproduction
ea0022s1.2
EUGOGO
ea0022s1.3
The EuroDSD project and consortium
ea0022s1.4
EurAdrenal
ea0022s1.5
The European Registry on Cushing's syndrome (ERCUSYN) database: first year experience
ea0022s1.6
Endocrine aspects about the metabolic syndrome
Brain-adipose and brain-liver connections in the metabolic syndrome
ea0022s2.1
Combined GH and IGF1 therapy
ea0022s2.2
Unacylated ghrelin: a metabolic hormone
ea0022s2.3
Testosterone treatment in the metabolic syndrome
ea0022s2.4
Bone cell biology
Skeletal stem cells and mechanisms of bone formation
ea0022s3.1
Cross talks between leptin and the skeleton
ea0022s3.2
The role of the hypothalamic-pituitary-thyroid axis in bone
ea0022s3.3
The aging male
Genetic aspects of ageing in men
ea0022s4.1
Osteoporosis in the aging male
ea0022s4.2
The natural history of symptomatic androgen deficiency in men: longitudinal results from the Massachusetts Male Aging Study
ea0022s4.3
Novel targets for thyroid cancer treatment
Novel targets for thyroid cancer treatment
ea0022s5.1
Molecular mechanisms in thyroid cancer
ea0022s5.2
Tyrosine kinase inhibitors in thyroid cancer
ea0022s5.3
Neuroendocrine control of reproduction
Sexual differentiation of hypothalamic Kiss1 neurons
ea0022s6.1
KNDy (kisspeptin/neurokinin B/dynorphin) cells of the arcuate nucleus: a central node in the control of GnRH secretion
ea0022s6.2
Consequences of non-classical ER[alpha] signaling in brain
ea0022s6.3
Insulin regulation of reproductive brain: rodent and human studies
ea0022s6.4
Approaches to preservation of gonadal function after cancer therapy
Ovarian transplantation
ea0022s7.1
ART/IVF and cryopreservation
ea0022s7.2
Oocyte cryopreservation
ea0022s7.3
Endocrine tumours: new genes and association with syndromes
Pituitary adenoma predisposition caused by AIP germline mutations
ea0022s8.1
New multiple endocrine neoplasias: endocrine tumors associated with gastrointestinal stromal tumors (GISTs)
ea0022s8.2
Update on familial pituitary tumors: from multiple endocrine neoplasia type I to familial isolated pituitary adenomas
ea0022s8.3
The role of oxidative stress in the development of the metabolic syndrome
Mitochondrial dysfunction and insulin resistance
ea0022s9.1
Macrophage dysfunction and insulin resistance
ea0022s9.2
Marked improvement of insulin resistance by reduced age intake; a non-pharmacologic, non-nutrient based intervention for type 2 diabetes
ea0022s9.3
Novel aspects in the treatment of bone disease
Principles of bone biology (the major pathways, RANKL, SOST, Wnt etc)
ea0022s10.1
Preclinical and clinical effects of RANK ligand inhibition
ea0022s10.2
Teriparatide and parathyroid hormone in the treatment of ostoporosis
ea0022s10.3
Premature ovarian failure
A pivotal role for NR5A1 in human reproductive processes
ea0022s11.1
Premature ovarian failure due to overactivation of primordial follicles in mice
ea0022s11.2
Ovarian AMH: implications for the diagnosis of premature ovarian failure
ea0022s11.3
Genetic defects in ovarian growth/differentiation factors
ea0022s11.4
Thyroid hormone metabolism and action: new developments
Thyroid hormone transporters
ea0022s12.1
Life without T4 to T3 conversion
ea0022s12.2
Thyroid hormone signalling in the heart
ea0022s12.3
Significance of thyroid hormone receptor [alpha] in metabolism
ea0022s12.4
The TSH reference range
Determinants of the TSH reference range
ea0022s13.1
Health outcomes related to TSH values within the reference range
ea0022s13.2
A critical synopsis of meta-analysis in the field of subclinical thyroid disease
ea0022s13.3
Solving the dilemma: what to do as a simple clinician
ea0022s13.4
Novel actions of vitamin D
Vitamin D and diabetes
ea0022s14.1
Vitamin D and Wnt signalling in colon cancer
ea0022s14.2
Vitamin D dependent anti-microbial pathways
ea0022s14.3
Vitamin D and differentiation of mesenchymal stem cells and osteoblasts
ea0022s14.4
Wnt signalling
Wnt/[beta]-catenin controls stem cells in regeneration and tumor formation
ea0022s15.1
Wnt-signaling and the metabolic syndrome
ea0022s15.2
Adipogenesis, diabetes and wnt signalling
ea0022s15.3
Hot topics in pituitary disease
Pros and cons of large scale screening of Cushing's syndrome
ea0022s16.1
The safety of dopamine agonists: clinical perspectives
ea0022s16.2
Problems with GH and IGF1 assays: progress?
ea0022s16.3
Genetic basis of infertility: clinical studies and clinical models
Genetically modified mouse models for the analysis of reproductive disorders
ea0022s17.1
Neurokinin B signaling in human puberty
ea0022s17.2
Genetics of Kallmann syndrome
ea0022s17.3
Diabetes in pregnancy
Progress towards new criteria for diagnosis and classification of glucose metabolism during pregnancy
ea0022s18.1
New treatment modalities in diabetic pregnancy
ea0022s18.2
Gestational diabetes: high risk for future diabetes and cardiovascular disease
ea0022s18.3
Fetal microchimerism as an explanation of disease
Microchimerism: introduction and animal models
ea0022s19.1
Molecular microchimerism detection: its importance for non-invasive prenatal diagnosis and preeclampsia
ea0022s19.2
The role of microchimerism in autoimmune diseases
ea0022s19.3
The endocrine incidentaloma
The endocrine incidentaloma
ea0022s20.1
Pituitary incidentalomas
ea0022s20.2
Adrenal incidentalomas
ea0022s20.3
The cardiometabolic interface
Endothelial dysfunction in type 2 diabetes
ea0022s21.1
Role of PPAR signalling in diabetic dyslipidemia
ea0022s21.2
Mechanisms and treatment of diabetic dyslipidemia
ea0022s21.3
MicroRNAs in endocrinology
MicroRNAs in biology
ea0022s22.1
MicroRNAs in thyroid cancer
ea0022s22.2
The role of miRNAs in hormone signaling
ea0022s22.3
Obesity: clinical manifestations and therapeutic intervention
Obesity: clinical manifestations and therapeutic: does the choice of diet make any difference?
ea0022s23.1
Lifestyle intervention and pharmacological approaches to weight loss
ea0022s23.2
Hormonal changes after bariatric surgery
ea0022s23.3
Diagnosis and treatment of endocrine malignancies
Malignant pheochromocytomas or paragangliomas
ea0022s24.1
Diagnosis and treatment of adrenocortical carcinomas
ea0022s24.2
Parathyroid carcinoma
ea0022s24.3
Non-classical responses to hormones
Rapid androgen action in epithelial and stromal cells
ea0022s25.1
Non-classical actions of estrogens in endocrine pancreas
ea0022s25.2
Protein kinase D as a modulator of aldosterone action in the kidney
ea0022s25.3
Extranuclear effects of thyroid hormones
ea0022s25.4
Adverse effects of drugs on thyroid
Tyrosine kinase inhibitors and thyroid
ea0022s26.1
Treatment of amiodarone-induced thyrotoxicosis (AIT) type 2: a RCT
ea0022s26.2
Interferons and the thyroid
ea0022s26.3
Multifaceted aspects of neuroprotection
Relationship between oestrogen and cholesterol in neuroprotection
ea0022s27.1
Relationship between oestrogen and cholesterol in neuroprotection
ea0022s27.2
Progesterone and the nervous system
ea0022s27.3
Oestrogen and corticotrophin releasing hormone: two hormones with different targets in neuroprotection
ea0022s27.4
Hypothalamic networks and energy homeostasis
PYY and the regulation of appetite control
ea0022s28.1
Brain lipogenesis and the control of food intake: the lipostatic hypothesis revisited
ea0022s28.2
Hypothalamic plasticity and the central control of energy balance
ea0022s28.3
Highlights
Oral Communications Highlights 1
PEX11[beta] deficiency impaired ossification by indirectly activating PPAR[gamma] expression and diminishing Runx2 activity
ea0022h1.1
Novel pathogenetic pathways of adrenocortical tumors revealed by meta-analysis of genomics data
ea0022h1.2
Frequent phosphodiesterase 11a (pde11a4) gene mutations in patients with carney complex (cnc) due to prkar1a mutations and adrenal (ppnad) and Sertoli cell tumors (lccsct): a digenic disorder?
ea0022h1.3
Physiological rescue by functional complementation of mutated LH receptors in transgenic mice
ea0022h1.4
Different genes are involved in Pendred's syndrome and in enlarged vestibular aqueduct syndrome
ea0022h1.5
Oral Communications Highlights 2
The endocannabinoid action in the regulation of energy balance is mainly due to the CB1 receptor in the forebrain neurons
ea0022h2.1
Human recombinant GH replacement therapy in children with pseudohypoparathyroidism type Ia and GH deficiency: first study on the effect on growth
ea0022h2.2
Subtle cognitive impairments in patients with long-term cure of Cushing's disease
ea0022h2.3
TAC3 and TACR3 'Knockouts' cause hypothalamic congenital hypogonadotropic hypogonadism in humans
ea0022h2.4
Effects of leptin administration on starvation-induced alterations in hepatic thyroid hormone metabolism in mice
ea0022h2.5
Oral Communications
Diabetes and obesity
Role of newly identified immunosuppressive NK cells in autoimmunity
ea0022oc1.1
Glucose insulinotropic peptide (GIP) secretion in type 2 diabetic and obese non-diabetic persons examined by meal test
ea0022oc1.2
NME7: a new candidate gene for T2DM
ea0022oc1.3
The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction
ea0022oc1.4
Role of PKA regulatory subunit R2B in murine and human adipocyte differentiation
ea0022oc1.5
Variation in response to exercise in type 2 diabetes associated to VEGFA and PGC1-[alpha] expression
ea0022oc1.6
Thyroid
Calcitonin screening and pentagastrin testing: predictive value for diagnosis medullary carcinoma in nodular thyroid disease
ea0022oc2.1
Systemic sodium iodide symporter (NIS) gene transfer in hepatocellular carcinoma using EGF-receptor targeted non-viral gene delivery vectors
ea0022oc2.2
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies
ea0022oc2.3
Polyglandular autoimmunity in autoimmune thyroid disease behaves differently from polyglandular autoimmunity in type 1 diabetes
ea0022oc2.4
Thyroid dysfunction related abnormalities in adiponectin and glucose metabolism before and after treatment
ea0022oc2.5
Percutaneous laser ablation (PLA) in non-functioning benign thyroid nodules: a 3-year follow-up study
ea0022oc2.6
Pituitary
Sgk1 effects on POMC transcription and ACTH release are opposite to those of glucocorticoids
ea0022oc3.1
Copeptin, an arginine vasopressin (AVP) marker, as a diagnostic aid in SIADH of cancer
ea0022oc3.2
Trauma severity, but not hypopituitarism, affects cognitive function after traumatic brain injury: a multi-center study in The Netherlands
ea0022oc3.3
Influence of the d3-GH receptor polymorphism on the metabolic and biochemical phenotype of GH deficient adults at baseline and during short- and long-term rhGH replacement therapy
ea0022oc3.4
Cortisol, but not ACTH/CRH, increases circulating ghrelin in man
ea0022oc3.5
Young patients with sporadic macroadenomas as target population for AIP mutations screening
ea0022oc3.6
Adrenals
Subtype differentiation in primary hyperaldosteronism: evaluation of alternative algorithms avoiding a controversial gold standard
ea0022oc4.1
A mouse model with hyperaldosteronism carrying an ENU induced mutation on chromosome 9
ea0022oc4.2
Novel mutations in the glucocorticoid receptor gene: from familial bilateral adrenal hyperplasia to glucocorticoid receptor haploinsufficiency
ea0022oc4.3
Combined anticortisolic therapy by metyrapone, ketoconazole and mitotane: an alternative to adrenalectomy in severe Cushing's syndrome
ea0022oc4.4
Effects of mitotane on testicular adrenal rest tumors size, sperm count and adrenal steroidogenesis in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
ea0022oc4.5
Serum cortisol predicts increased cardiovascular mortality in patients with acute coronary syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
ea0022oc4.6
Reproduction & Thyroid
Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model
ea0022oc5.1
The influence of cure of subclinical hyperthyroidism on diastolic diameters of heart chambers and cardiac index
ea0022oc5.2
Socio-economic factors and mortality in Turner syndrome: a registry study
ea0022oc5.3
One hormone, two functions: the chorionic gonadotropin in New World Monkeys
ea0022oc5.4
Predictive factors of intermittent ovarian function in patients with premature ovarian failure
ea0022oc5.5
Universal screening detects twice more thyroid disorders in early pregnancy than targeted high-risk case finding
ea0022oc5.6
Bone
A proteomic approch to study parathyroid glands
ea0022oc6.1
Association between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism
ea0022oc6.2
Six novel mutations in 25-hydroxyvitamin D3 1[alpha] hydroxylase gene in patients with pseudovitamin D deficiency rickets
ea0022oc6.3
Age-dependent features of bone mineral density changes in male rats with hyperthyroidism
ea0022oc6.4
The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma
ea0022oc6.5
Suppression of circulating fibroblast growth factor-23 by cinacalcet in patients with primary hyperparathyroidism
ea0022oc6.6
Poster Presentations
Adrenal
Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound
ea0022p1
Alterations in lipid and carbohydrate metabolism in patients with classic CAH due to 21-hydroxylase deficiency
ea0022p2
Glucocorticoid receptor polymorphisms and metabolic-cardiovascular impairment in adult patients with Addison's disease under glucocorticoid replacement therapy
ea0022p3
Clinically silent adrenal incidentalomas: their relation to metabolic syndrome and to GNB3 C825T gene polymorphism
ea0022p4
Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome: a longitudinal study
ea0022p5
Supine and upright plasma renin (PR) and aldosterone (ALD) in patients with adrenal incidentaloma (AI)
ea0022p6
Beneficial metabolic effects of surgical treatment in patients with an adrenal incidentaloma causing subclinical hypercortisolism
ea0022p7
The consideration of external steroid therapy history and skin bruising sign with morning serum cortisol measurement predicts better results of rapid ACTH stimulation test than morning serum cortisol only
ea0022p8
A high prevalence of primary hyperaldosteronism in hypertensive patients
ea0022p9
Cushing's syndrome: screening and diagnosis aspects
ea0022p10
Effects of atenolol add-on treatment on plasma renin activity (PRA) and aldosterone escape in hypertensive patients with diabetes receiving valsartan
ea0022p11
Autoimmune disorders in Addison's disease and in isolated secondary adrenal insufficiency
ea0022p12
Pharmacokinetic evidence for hydrococortisone under and over replacement in adrenal insufficiency
ea0022p13
Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate as markers of disease severity in community-acquired pneumonia
ea0022p14
Pheochromocytoma in an incidentally discovered cystic adrenal mass: a case report
ea0022p15
Secondary adrenal failure due to sepsis
ea0022p16
Salivary cortisol in the diagnosis of Cushing's syndrome: clinical experience with liquid chromatography/tandem mass spectrometry on outpatient basis
ea0022p17
The aldosterone renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma
ea0022p18
Adrenal incidentalomas accompanying malignant tumours: clinical study of 1888 patients
ea0022p19
Comparison between ultrasonography versus other standard imaging procedure in diagnostics of pathological changes of adrenal glands
ea0022p20
Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects
ea0022p21
Comparison of the in vitro effects of ketoconazole and fluconazole on human primary adrenocortical cultures and on the adrenocortical carcinoma cell line HAC15
ea0022p22
Sunitinib decreases adrenocortical cancer cell proliferation and specifically inhibits adrenal steroidogenesis
ea0022p23
Two cousins with 17-[alpha] hydroxylase enzyme deficiency
ea0022p24
Morphological, functional and metabolic features in a series of 63 patients with adrenal incidentalomas
ea0022p25
Confirmation of vitamin D receptor polymorphism TaqI and detection of a new single nucleotide polymorphism (SNP) in the CTLA4-region (CTLA4-CT60) as susceptibility markers for Addison's disease
ea0022p26
Spontaneous recovery of bone mass after cure of endogenous hypercortisolism
ea0022p27
Predictors for cure and normotension after adrenalectomy for primary aldosteronism
ea0022p28
Benefit to risk ratio of mitotane high starting dose strategy in 22 patients with adrenocortical carcinoma (ACC): a prospective evaluation
ea0022p29
Primary adrenocortical sarcomatous carcinoma: case report
ea0022p30
Adrenocortical cancer: any hope? case reports
ea0022p31
Utility of midnight salivary cortisol measurement in the diagnosis of overt and subclinical Cushing's syndrome
ea0022p32
Adrenal incidentalomas and low grade hormonal activity
ea0022p33
Aberrant adrenal LH receptors leading to subclinical Cushing's syndrome: long-term effect of medical treatment with leuprolide acetate
ea0022p34
Conservation and divergence in transcriptional regulation of human CYP11B1 and CYP11B2 genes
ea0022p35
Free cortisol in plasma and saliva samples after synacthen testing in a routine exploration of patients in endocrinology
ea0022p36
Inactivation of PRKARIA or PRKAR2B increases cell proliferation and decreases apoptosis, delineating distinct molecular mechanisms in adrenocortical human H295R cell line
ea0022p37
Cortisol resistance in a HIV infected patient
ea0022p38
The measurement of epicardial fat thickness is an index of cardiometabolic risk in patients with adrenal incidentaloma
ea0022p39
Higher cortisol response to glucose load in patient with adrenal adenomas and subclinical Cushing (SC)
ea0022p40
Response of human adrenocortical carcinoma to mitotane treatment in vitro
ea0022p41
Increased prevalence of metabolic syndrome in patients with subclinical autonomous cortisol hypersecretion by adrenal incidentalomas
ea0022p42
Comparison of physiological and endocrine responses of rainbow trout (Oncorhynchus mykiss) after electroanesthesia and anesthesia with MS222 and clove oil
ea0022p43
Pheochromocytoma of the adrenal gland scaled score (PASS) as a predictor of aggressive biologic behaviour
ea0022p44
High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: implications to management
ea0022p45
Profile of cortisol changes during early stages of development in rainbow trout
ea0022p46
Genomic DNA alterations in adrenocortical tumors (ACTs): diagnostic and prognostic value
ea0022p47
Combined primary aldosteronism and preclinical Cushing's syndrome due to a large adrenocortical adenoma
ea0022p48
In vitro effect of dopastatins on hormone secretion in adrenal tumors
ea0022p49
Under-expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone producing adenoma causing human primary aldosteronism
ea0022p50
In vitro effect of serotonin (5-HT) on cortisol secretion in primary pigmented nodular adrenal disease
ea0022p51
Expression of mTOR and IGF2 and in vitro effects of mTOR inhibitor drugs on cell proliferation and cortisol production in human adrenocortical cancer cells
ea0022p52
Primary bilateral adrenal lymphoma without adrenal insufficiency: a case report
ea0022p53
Cushing's syndrome in children: new faces of the old one
ea0022p54
Influence of various clinical variables and storage conditions on urinary cortisol levels: gas chromatography-mass spectrometry (GC-MS) versus immunoassay
ea0022p55
Arterial and venous thrombotic events in Cushing's syndrome
ea0022p56
Influence of short-term glucocorticoid therapy on regulatory T cells
ea0022p57
Long-term follow-up of patients with adrenal incidentalomas: a single center experience
ea0022p58
QTc and P wave dispersion in patients with Cushing's syndrome
ea0022p59
Laparoscopic adrenalectomy: 12-year experience in a single institution
ea0022p60
Comparison of plasma aldosterone/signal activity and aldosterone/active signal ratios in different clinical conditions
ea0022p61
Adrenal incidentaloma; a case report
ea0022p62
Adrenal non-producing adenomas show indirect signs of glucocorticoid excess and hypercortisolism correlates with differential blood counts
ea0022p63
Endothelial cell-derived products regulate [beta]-catenin-dependent transcription in human adrenocortical cells
ea0022p64
Sporadic solitary aldosterone- and cortisol-cosecreting adenomas: a subtype of primary aldosteronism
ea0022p65
The HLA-DRB1 shared epitope and trans-encoded HLA-DQ-heterodimers hypothesis in autoimmune Addison disease
ea0022p66
Bone/Calcium
Estimation of ionized calcium levels after thyroidectomy at King Abdul Aziz University Hospital (Jeddah)
ea0022p67
Imatinib mesylate disturbs bone growth and remodellation in postnatal rats
ea0022p68
Parathyroid hormone levels in hemodialysis patients
ea0022p69
Bone mineral density in Ukrainian women of different age with thyrotoxicosis
ea0022p70
Relationship of serum leptin and bone mineral density in patients with type 2 diabetes mellitus
ea0022p71
Study implications osteoporosis in gonadal disgenesias
ea0022p72
Bone mineral density study and biochemical markers of bone turnover in premature ovarian failure
ea0022p73
Delayed puberty and bone turnover biochemical markers
ea0022p74
Structural heart disease in osteogenesis imperfecta: a case-control study
ea0022p75
Osteomalacia: important cause of bone loss in a patient with inflamatory bowl disease: case report
ea0022p76
The effect of zoledronic acid on serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone
ea0022p77
Angiotensin converting enzyme I/D and M235T angiotensinogen gene polymorphism in patients with acromegaly
ea0022p78
Cutoff point, upper and lower QUS parameters values in diagnosing demineralisation in cases with ESRD
ea0022p79
Secondary hypoparathyroidism in thalassaemia and sickle cell anaemia
ea0022p80
Abnormalities in calcium, phosphorus and parathyroid hormone in patients with end stage chronic kidney disease on hemodialysis
ea0022p81
An unusual cause of life-threatening hypercalcaemia treated with haemodialysis
ea0022p82
The markers of bone remodelling in postmenopausal osteoporosis
ea0022p83
Effect of strontium ranelate on vertebral pain syndrome in postmenopausal women with systemic osteoporosis treatment
ea0022p84
Giant mediastinal parathyroid adenoma, a rare cause of severe acute hyperparathyroidism
ea0022p85
Mandibular radiomorphometric indices as predictors of osteopenia and osteoporosis in postmenopausal women
ea0022p86
Asymptomatic primary hyperparathyroidism: current indications for final solution
ea0022p87
Vitamin D and calcium status in women with postmenopausal osteoporosis
ea0022p88
Comparison of alendronate and raloxifene as a medical treatment option in patients with primary hyperparathyroidism
ea0022p89
Primary hyperparathyroidism: retrospective evaluation
ea0022p90
Long-term follow-up of the changes in serum 25-hydroxivitamin D to oral treatment with vitamin D3 in patients with postmenopausal osteoporosis
ea0022p91
Management of primary hyperparathyroidism in Spain: a national survey
ea0022p92
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency
ea0022p93
Dissimilar PTH, gastrin, and ionized calcium response to oral peptones in normocalcemic primary hyperparathyroidism, hypercalcemic primary hyperparathyroidism and normal subjects
ea0022p94
Cross-validated calculation procedure to assess the cholecalciferol loading dose for rapid correction of vitamin D deficiency
ea0022p95
Hypoparathyroidism mimicking ankylosing spondylitis
ea0022p96
Multiple osteoporotic fractures in myasthenia gravis patient receiving short-term prednisolone therapy
ea0022p97
Teriparatide in the treatment of severe osteoporosis: results of a multicenter prospective study
ea0022p98
Vitamin D deficiency and comorbidity
ea0022p99
Vitamin D status among adults in the Aegean region of Turkey
ea0022p100
Fine needle aspiration of parathyroid gland with PTH analysis in washouts: is it worthy?
ea0022p101
Positive effect of human adipocyte-secreted factors on human osteoblast proliferation and the OPG/RANKL ratio in vitro
ea0022p102
Tumoral calcinosis likely due to end-organ resistance to FGF23
ea0022p103
Wermer syndrome revealed by primary hyperparathyroidism: a case report
ea0022p104
Severe primary hyperparathyroidism related multiple clear cell adenome
ea0022p105
Osteocalcin, OPG and RANKL circulating levels in adolescent idiopathic scoliosis
ea0022p106
Parathyroid FNA with PTH determination as a tool in primary hyperparathyroidism diagnosis - case report
ea0022p107
Bone turnover, serum osteoprotegerin and soluble receptor activator of nuclear factor-K
ligand levels in patients with hyperthyroidism
ea0022p108
Primary hyperparathyroidism at pregnancy
ea0022p109
Comparative evaluation of bone density measurement with DXA or quantitative ultrasound of bone in the diagnosis and treatment monitoring of osteoporosis - a field study
ea0022p110
Osteoporosis and osteopenia in patients after the organ transplantation
ea0022p111
Risk of vertebral fractures in osteoporotic women: definition of a clinically relevant scale of risk
ea0022p112
Diagnostic challenge in child's bone cystic lesions
ea0022p113
Male osteoporosis of multiple drug aetiology
ea0022p114
Extraosseous effects of raloxifene in osteoporotic postmenopausal women
ea0022p115
Polyunsaturated fatty acids omega-3, but not the omega-6, stimulates the differentiation to osteoblasts of mesenchymal stem cell
ea0022p116
Evaluation of age and sex influence on the morphometric parameters of vertebrae in densitometric morphometry - results of EPOLOS study
ea0022p117
Primary hyperparathyroidism diagnosis - new insights of an old dilemma
ea0022p118
PTH treatment in adult hypophosphatasia: significant increase in S-AP, improvement of pain and fracture healing in two siblings with ALPL gene mutations G339R and E191K
ea0022p119
Estradiol and testosterone levels in diabetic type 2 men with low bone density and osteoporosis
ea0022p120
The circadian rhythm of bone resorption: comparison between patients treated with teriparatide and patients with primary hyperparathyroidism
ea0022p121
Primary hyperparathyroidism: laboratory associations and thyroid pathologies
ea0022p122
Cardiovascular endocrinology and lipid metabolism
Interrelation between bone mineral density and lipid profile in postmenopausal women
ea0022p123
Levels of adiponectin and tumor necrosis factor-alpha in members of families with familial combined hyperlipidemia
ea0022p124
Cardiovascular disease and risk factors in patients with type 2 diabetes in IRAN
ea0022p125
The effect of erythropoietin treatment on insulin resistance and inflammatory markers in patients on maintenance hemodialysis
ea0022p126
Subjects homozygous for the BCL1 polymorphism of glucocorticoid receptor gene may have an increased risk for impaired endothelial function
ea0022p127
Leptin and its associations with complications of acute myocardial infarction in patients with the metabolic syndrome
ea0022p128
Obesity and metabolic syndrome during the menopausal transition of women in Serbia
ea0022p129
The effects of adiponectin gene polymorphisms on the progression of carotid intima-media thickness
ea0022p130
Associations between the metabolic syndrome and bone mineral density in Ukrainian women in postmenopausal period
ea0022p131
Prevalence of metabolic syndrome in a working population of strategic services
ea0022p132
Are the thyroid functions associated with widespread of acute coronary syndromes?
ea0022p133
Effects of cross-sex hormone treatment in young transsexual subjects
ea0022p134
Insulin secretion and HOMA-IR in patients who underwent coronary angiography
ea0022p135
Serum ferritin and risk of the metabolic syndrome in cross-sex hormone-treated transsexuals
ea0022p136
FABP4 inhibitor strongly depresses cardiac function
ea0022p137
Calculation of cardiovascular risk in firefighters
ea0022p138
Echocardiographic epicardial fat thickness in acromegaly patients
ea0022p139
Atrial natriuretic peptide (ANP) attenuates lipid peroxidation in anesthetized atherosclerotic male rabbits by reduction of renin-angotensin-aldosterone system (RAAS) activity
ea0022p140
Serum IGF1 levels correlate to improvement of functional independence after ischemic stroke
ea0022p141
Insulin mediates the glucagon-induced decrease in atrial natriuretic peptide: a randomized controlled trial
ea0022p142
Osteopontin, adiponectin and peripherical arterial disease in patients with type 2 diabetes
ea0022p143
Clinical approach to hypertensive patients: matter of trust between doctor and patient
ea0022p144
Ligands of receptor for advanced glycation end-products in stable coronary artery disease: their potential contribution to atherogenesis exceeds beyond diabetes mellitus
ea0022p145
Acromegaly and endothelial dysfunction: is there any relation between?
ea0022p146
Gender variations of serum Paraoxonase-1 activities in healthy young men and women: association with carotid intimae media thickness
ea0022p147
Searching for the metabolic syndrome criteria in young adults with hypogonadism
ea0022p148
Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction
ea0022p149
Genetic polymorphisms associated with cardiovascular risk correlate with dyslipidaemia in healthy postmenopausal women
ea0022p150
Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?
ea0022p151
Relationship between serum IL-12 and p40 subunit concentrations and lipid parameters in obese subjects
ea0022p152
Heart rate variability in adults with hypopituitarism and severe growth hormone deficiency
ea0022p153
Increased plasma resistin concentrations are associated with atherogenic small, dense low-density lipoproteins in patients with type-2 diabetes
ea0022p154
Increased plasma viscosity is a predictor of high cardiovascular risk in women with PCOS
ea0022p155
The impact of testosterone replacement therapy on endothelial function in hypogonadal men with type 2 diabetes
ea0022p156
Alterations of plasminogen activator inhibitor-1, myeloperoxidase and matrix metalloproteinase-9 in coronary artery disease patients with type-2 diabetes mellitus
ea0022p157
Osteoprotegerin and angiotensin II in type 2 diabetes
ea0022p158
Changes in serum concentrations and tissue expression of fibroblast growth factor-21 during and after elective major cardiac surgery
ea0022p159
MRI-assessed visceral adipose tissue (VAT) in different lipodystrophic (LD) syndromes
ea0022p160
Possibility for the Metformin administration in post-infarction period in patients with the 2-nd type of DM
ea0022p161
The effect of testesterone replacement therapy on HDL subfraction levels in hypogonadotropic hypogonadism
ea0022p162
Pitfalls in endocrine assessment of systemic hypertension in young people
ea0022p163
Correlation of plasma B-type natriuretic peptide (BNP) levels with electrocardiographic (ECG) signs of right ventricular strain in patients with acute pulmonary embolism
ea0022p164
Male sexuality and cardiovascular risk: a cohort study in patients with erectile dysfunction
ea0022p165
CRH and Urn2 regulate NO bioavailability, ROS levels and antioxidant defence systems in endothelial cells
ea0022p166
Structural and functional carotid wall alterations in controlled versus active acromegaly
ea0022p167
Sexual dimorphism of cardiovascular ischemia susceptibility is mediated by heme-oxigenase synthase
ea0022p168
Bcl1 polymorphysm of glucocorticoid receptor gene in coronary artery disease
ea0022p169
Formation of neutralizing anti human growth hormone (hGH) antibodies does not explain the lack of IGF1 increase after recombinant hGH treatment in mice
ea0022p170
Clinical case reports and clinical practice
Parathyromatosis coincidentally associated with papillary (Sclerosing) microcarcinoma of the thyroid
ea0022p171
Carcinoid syndrome: case report
ea0022p172
Insulin-induced lipohypertrophy, past, present and future-are we losing the battle?
ea0022p173
'Sound mind' and lithium-induced hyperparathyroidism
ea0022p174
Fenofibrate-induced rhabdomyolysis and acute renal failure in patient with occult hypothyroidism
ea0022p175
Quality management system of regional and general hospital medical laboratory in relation to ISO 15189:2007, Thailand
ea0022p176
Pursuit endocrinology - perceptions, understanding and reactions of students undertaking internal medicine training regarding endocrinology
ea0022p177
Glass fiber containing materials - a rare cause of granulomatous mastitis
ea0022p178
Screening for nutritional status in the elderly
ea0022p179
Papillary thyroid carcinoma in a patient with intestinal ganglioneuromatosis
ea0022p180
Syndrome of inappropiate antidiuresis hormone associated with multiple sclerosis
ea0022p181
Occult ACTH-secreting pheochromocytoma
ea0022p182
Metastasis to the thyroid gland with thrombo embolic jugular involvement as initial presentation of renal carcinoma: a Case Report
ea0022p183
Emergency use of etomidate in acute steroid psychosis for an adrenal cancer causing Cushing's syndrome
ea0022p184
Primary biliary cirrhosis and Graves' disease - combination rarely found
ea0022p185
Pseudophaeochromocytoma: case series of a common cause
ea0022p186
An uncommon case of Carney's triad
ea0022p187
Case report of Borrelia burgdorferi infection as a possible trigger of Riedel's thyroiditis
ea0022p188
Liver toxicity after methylprednisolone treatment of Graves orbitopathy
ea0022p189
Cryopreserved organ culture of endocrine glands for hormonal insufficiency treatment
ea0022p190
Nonclassic 11
-hydroxylase deficiency with hypofunctional polymorphisms on both haplotype
ea0022p191
Approaches to the diagnosis and management of primary hyperparathyroidism in Europe results from a European Survey in five countries
ea0022p192
An unusual case of acromegaly
ea0022p193
Thyroid storm accompanied by H1N1 influenza infection
ea0022p194
A rare cutaneous manifestation in Cushing's syndrome: generalized pustular psoriasis
ea0022p195
A rare cause of elevated liver enzymes: Addison's disease
ea0022p196
Genetic pattern of sex development disorders: cases report
ea0022p197
Administration of testosterone to elderly hypogonadal men with Crohn's disease improves their Crohn's disease activity index: a pilot study
ea0022p198
Papillary thyroid carcinoma metastasis to the parapharyngeal space
ea0022p199
Evolution of thyroid angiosarcoma under complex therapy: a case report
ea0022p200
A successfull case of pregnancy in a woman with ACTH-independent Cushing's syndrome
ea0022p201
Oral bisphosphonates - therapeutical results after two years treatment in osteogenesis imperfrecta type Ia
ea0022p202
Long-standing testicular adrenal rest tissues in a patient with congenital adrenal hyperplasia due to 11-beta hydroxylase deficiency with homozygous mutation l299p in the Cyp11b1 gene
ea0022p203
Ganglioneuroblastoma: a rare cause of adrenal mass in adults
ea0022p204
Amiodarone induced thyreopaties
ea0022p205
The role of salivary [alpha]-amylase in prediction of failure of smoking cessation
ea0022p206
Childhood nephrogenic diabetes insipidus revealed by urinary megabladder in two adult male brothers
ea0022p207
A family with Von Hippel - Lindau disease (VHL)
ea0022p208
The use of an algorithm to aid diagnosis and treatment of patients with hyponatraemia secondary to SIADH
ea0022p209
Two rare genetic causes of aberrant growth: Robinow syndrome with partial GH deficiency and dwarfism and Simpson-Golabi-Behmel syndrome with gigantism
ea0022p210
Unilateral Graves' orbitopathy and autoimmune atrophic thyroiditis: case report
ea0022p211
The difficulties of Cushing' s disease - case report
ea0022p212
The role of octreotide in the management of young patients with acromegaly
ea0022p213
Thyroid antibodies and renal function
ea0022p214
The etiologic profile of short stature in the south west of Romania between 2004-2009
ea0022p215
10 years experience with somatostatin analogue (SSA) treatment in multiple endocrin neoplasia type 1 (a case report)
ea0022p216
Malignant corticotrophinoma - a clinical report
ea0022p217
Differences in TSH lowering effect of metformin in hypothyroid and euthyroid type 2 diabetic patients
ea0022p218
Secondary osteoporosis and secondary hyperparathyroidism in patient with Hashimoto thyroiditis and coeliac disease (case report)
ea0022p219
Primary ovarian carcinoid presenting as right heart failure - case report
ea0022p220
Two therapeutic approaches for thyrotropin-secreting pituitary adenomas
ea0022p221
A retroperitoneal neuroendocrine tumour pre-diagnosed as an adrenal incidentaloma - a case report
ea0022p222
Hypoparathyroidism related epilepsy
ea0022p223
Graves' disease, systemic lupus erythematosus, hypoparathyroidism: autoimmune polyglandular syndrome or coincidence?
ea0022p224
Necrotizing fasciitis as a complication of subcutaneous injection of insulin in a diabetic patient: a case report
ea0022p225
Pancreatic graft arterial thrombosis after coronary artery catheterization - an unusual case of pancreas allograft rejection
ea0022p226
Hypogonadotropic hypogonadism in POEMS syndrome - case report
ea0022p227
Cushing's syndrome as presentation of an ACTH-producing pulmonary tumour
ea0022p228
Dose of growth hormone (GH) and not IGFI level at treatment start influences treatment outcome in GH deficient adults (GHDA): Data from the NordiNet International Outcome Study (IOS)
ea0022p229
Fluctuating bilateral abducent palsy leading to the diagnosis of pituitary mass without cavernous sinus involvement. How does this match?
ea0022p230
Isolated parietal-skull metastasis from a thyroid papillary carcinoma
ea0022p231
Benign symmetric lipomatosis (Madelung's disease): a case report
ea0022p232
Pheochromocytoma associated with thyroid papillary carcinoma: a report of an unusual case
ea0022p233
Primary adrenal failure of tuberculous aetiology and vitamin D deficiency
ea0022p234
Carbimazole induced neutropenia: are we too cautious?
ea0022p235
Carbimazole pseudo-resistance: two case reports
ea0022p236
Estimation of parathyroid hormone level in patients with primary hyperparathyroidism (PHPT) and negative SPECT scans in the material obtained during fine needle aspiration biopsy (FNAB) of the focal neck lesions
ea0022p237
A case of severe hypocalcaemia post liver transplantation
ea0022p238
Causes and patterns of death in an endocrinology clinic: data of six years
ea0022p239
Synergic effect of Cabergoline in acromegaly treated with somatostatin analogues. Report of two cases
ea0022p240
Macroprolactinoma after chronic buserelin treatment in patient with prostate cancer
ea0022p241
Diagnostic performance evaluation of marking the concentration levels of procalcitonin and ProGRP in monitoring disease cases of patients with medullary thyroid carcinoma (MTC)
ea0022p242
Nesidioblastosis in adult patient with neurofibromatosis type1 and synchronous multicentric duodenal somatostatinomas - case report
ea0022p243
Polyuric-polydipsic syndrome after cranioencephalic traumatism in a patient with multiple sclerosis
ea0022p244
The course of disease and treatment of patient with MEN2A syndrome diagnosed in 9-th week of pregnancy
ea0022p245
Serum prolactin levels in rheumatoid arthritis and other autoimmune diseases
ea0022p246
A tale to tell: how lupus led to Graves' disease
ea0022p247
Tertiary hypercorticotropinism and Cushing's disease secondary to impaired 21-hydroxylation
ea0022p248
Cushing syndrome in patient with thyroid orbitopathy (case report)
ea0022p249
Different manifestations of polyglandular autoimmune syndrome in HLA-identical monozygous twins
ea0022p250
Comparative endocrinology
Relationship between essential amino acids and muscle mass, independent of habitual diets, in pre- and post-menopausal women
ea0022p251
Comparison of delayed puberty in girls and boys- Bosnian aspect
ea0022p252
Osmoregulatory related alterations in plasma levels of triiodothyronine and cortisol in a marine euryhaline teleost
ea0022p253
Growth hormone releasing hormone (GHRH)-like peptide (LP)-2 is a growth hormone (GH) releasing factor in chickens
ea0022p254
Pituitary adenylate cyclase-activating polypeptide related peptide (PRP) in an Anabantidae fish: its mRNA expression in the brain during gonadal development and sexual behavior and its hypophysiotropic effect on pituitary hormonal gene expression
ea0022p255
Developmental endocrinology
Similar developmental patterns of ghrelin and glucagon immunoreactivity in the human pancreas
ea0022p256
Mineralocorticoid pathway in newborns: evidence for a physiological renal aldosterone unresponsiveness
ea0022p257
De novo cholesterol synthesis in developing mouse embryo is required for embryonic survival
ea0022p258
Partial loss of pancreas endocrine and exocrine cells of human ARX-null mutation: consideration of pancreas differentiation
ea0022p259
Quality of life and emotional state of adult patients with adult-onset, childhood-onset growth hormone deficiency and Turner syndrome
ea0022p260
An inadequate maternal dietary protein level during pregnancy in pigs alters the expression of corticosteroid receptors and 11[beta]-hydroxysteroid dehydrogenase isoforms in the placenta and fetal brain
ea0022p261
Lipid profile in type 2 diabetic patients in Kragujevac
ea0022p262
Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Mullerian derivatives: comparison with the normal fetal development
ea0022p263
Baseline characteristics and serum IGF1 levels in GH deficient (GHD) patients treated in the transition phase from adolescence into adulthood: data from the NordiNet International Outcome Study (IOS)
ea0022p264
Maternal stress in early pregnancy: the reason of endocrine and behaviour disorders in female offspring
ea0022p265
Familial hypercalciuric hypercalcemia and severe neonatal hyperparathyroidism: a clinico-biochemical and molecular characterization in a Tunisian family
ea0022p266
Diabetes
Have the glitazones anything to do with fractures?
ea0022p267
Insulin-induced lipohypertrophy, past, present and future: are we losing the battle?
ea0022p268
Body mass index, disease duration and rheumatologic presentations in diabetes mellitus, Gorgan (North part of Iran)
ea0022p269
A case of diabetic ketoacidosis with ECG abnormalities mimicking acute coronary syndrome
ea0022p270
The role of ATP-sensitive potassium (KATP) channel in skeletal muscle insulin resistance: possible correlation with GLUT4 gene
ea0022p271
Depression, anxiety, quality of life and sleep in patients with type 1 diabetes mellitus
ea0022p272
The effect of diabetes treatment on non alcoholic fatty liver disorder
ea0022p273
Insulin resistance in smokers and non-smokers in young healthy population
ea0022p274
Benefit of switching from rosiglitazone to pioglitazone on cardiovascular markers in routine clinical practice
ea0022p275
Advanced glycation end products (AGEs) and high glucose in endothelial cells: gene expression analysis
ea0022p276
Comparison of lymphomononuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients
ea0022p277
Assessment of the therapeutic effectiveness of gliclazide MR after short-term application
ea0022p278
Effectiveness of patterns of intensification of premixed insulin analogue therapy
ea0022p279
Knowledge, attitudes and practices of type 1 diabetes patients regarding complementary and alternative medicine (CAM)
ea0022p280
The frequency of depression estimation among patients with diabetes mellitus
ea0022p281
The Gly972Arg polymorphism in the insulin receptor substrate-1 gene (IRS1) and the impact on type 2 diabetes mellitus
ea0022p282
Impact of the SUR1 16-3 C/T and INSR His 1085 C/T genetic variability on type 2 diabetes mellitus development
ea0022p283
Left ventricular hypertrophy and its relation with inflammation in type 2 diabetic patients
ea0022p284
Abstract unavailable
ea0022p285
It's time to put the 'age' and the 'face' on HbA1c in elderly patients with diabetes mellitus
ea0022p286
Depression, anxiety, quality of life and sleepiness in family members of type 2 diabetic patients
ea0022p287
Comparative and metabolic study of glycosylated hemoglobin, magnesium, nitrogenous metabolites, and lipid profile in diabetics and non-diabetics patients
ea0022p288
Association of diabetes mellitus with thalassaemia and sickle cell disease
ea0022p289
Response of interleukin-6 during euglycaemic and hyperglycaemic exercise in patients with type 1 diabetes mellitus
ea0022p290
Coagulation inhibitors in type 2 diabetes mellitus
ea0022p291
Linagliptin, a potent and selective DPP-4 inhibitor, does not prolong the QT interval when given in therapeutic and 20-fold supratherapeutic doses
ea0022p292
Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation
ea0022p293
In-patients insulin therapy protocol: establishment and valuation
ea0022p294
Insulin treatment intensification to basal-bolus in diabetic patients
ea0022p295
Prevalence of cardiovascular risk factors at the time of diagnosing type 2 diabetes mellitus: follow up in the endocrinologist's consultation
ea0022p296
Evaluation of effect of dose and duration of treatment with metformin on serum vitamin B12 levels in type 2 diabetic patients
ea0022p297
The IMPERIAL study: physicians' perceptions regarding intensification of insulin therapy
ea0022p298
A case of spontaneous pneumomediastinum and diabetic ketoacidosis in patient with diabetes mellitus which was undiagnosed before
ea0022p299
Inpatient hypoglycaemia: the continuing problem and need for a proactive management protocol
ea0022p300
Hypovitaminosis D and microvascular complications in diabetic patients
ea0022p301
Effects of interleukin-4 on energy metabolism
ea0022p302
Metabolic control in patients with type 1 diabetes mellitus in Belarus
ea0022p303
Psychological rehabilitation efficiency in adolescents with type 1 diabetes
ea0022p304
Latent autoimmune diabetes of adults and its clinical, immunological and genetics markers
ea0022p305
Exercise-related levels of acetylcarnitine in skeletal muscle of individuals with type 1 diabetes in Eu- and hyperglycaemia assessed by 1H-MR spectroscopy
ea0022p306
Association between dyslipidaemia and micro and macrovascular complications in type 2 diabetic patients
ea0022p307
Pattern of type 2 diabetes mellitus in Surabaya, Indonesia
ea0022p308
Metabolic syndrome in patients with type 2 diabetes mellitus in Surabaya, Indonesia
ea0022p309
Profile of patients with type 2 diabetes mellitus in Surabaya, Indonesia
ea0022p310
Risk estimation of hypoglycemic episodes among patients with type 1 diabetes mellitus
ea0022p311
The effects of short-term fasting on insulin sensitivity and inflammation in healthy subjects
ea0022p312
Fifty-two-week treatment with diet and exercise plus transdermal testosterone improves biomarkers of non-alcoholic fatty liver disease and cardiovascular risk in hypogonadal men with the metabolic syndrome
ea0022p313
Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes
ea0022p314
Vitamin D deficiency and isolated fasting hyperglycemia in pregnancy
ea0022p315
Postpartum evaluation of patients with gestational diabetes and newborns characteristics: differences between two periods
ea0022p316
Thyroid diseases in patients with type 1 diabetes mellitus
ea0022p317
Proinflammatory cytokines and serum lipids in patients with diabetes mellitus 2
ea0022p318
Non-invasive cytological method of diagnostics and monitoring of type 2 diabetes mellitus development
ea0022p319
Calcaneal spur incidence is increased in patients with type 2 diabetes mellitus
ea0022p320
Analysis of the clinical course of patients with type 2 diabetes mellitus from onset of insulin treatment (EDIN study): baseline characteristics of patients
ea0022p321
Badly controlled hyperglycaemia provokes arrhythmia and may increase cardiovascular risk in diabetic patients
ea0022p322
Etiologies of patients admitted to emergency department with hypoglycemia
ea0022p323
Dose--response characteristics for effects of insulin in patients with type 2 diabetes and severe insulin resistance: evidence for the utility of high doses of insulin
ea0022p324
Interrelation of changes of interval QT and indexes of metabolic control in children with diabetes mellitus type 1
ea0022p325
Pancreatic insulin secretion in women with polycystic ovary syndrome
ea0022p326
Chitotriosidase activity predicts endothelial dysfunction in type 2 diabetes mellitus
ea0022p327
Follow up of type 1 diabetic patients treated with insulin continuous s.c. infusion
ea0022p328
Effects of ghrelin treatment to promote proliferation of pancreatic islet in BB rats
ea0022p329
Lipid profile in patients with ST-segment elevation myocardial infarction with or without diabetes
ea0022p330
Transient insulin resistance during the laparoscopic versus open cholecystectomy
ea0022p331
The mean HbA1c values in T2DM according a therapy regiments
ea0022p332
Therapy with exenatide: our experience
ea0022p333
Prevalence of metabolic syndrome and diabetes mellitus type 2 under the conditions of the primary component of public health
ea0022p334
Adiponectin time dependence secretion under [beta]3 agonist, PPAR agonist treatments
ea0022p335
Therapeutic objectives in the care of patients with diabetes mellitus type 2 in clinical practice at an endocrine department
ea0022p336
The effect of short-term metformin therapy on C-reactive protein and insulin sensitivity in newly diagnosed patients with type 2 diabetes mellitus
ea0022p337
Vitamin D and glycaemic control
ea0022p338
Maternal obesity and gestational diabetes mellitus
ea0022p339
Performances of the fully automated Liaison[reg] system for determination of insulin and C-peptide concentrations
ea0022p340
Role of regulatory T-cells in the development of the partial remission period in patients with type 1 diabetes
ea0022p341
Lipid profile in women with gestational diabetes mellitus
ea0022p342
Increased insulin resistance is associated with increased urinary excretion of chromium in non-diabetic, normotensive Saudi adults
ea0022p343
Systemic effect of insulin on local cytokine concentrations in adipose tissue and muscle in healthy humans
ea0022p344
Decreased serum brain-derived neurotrophic factor concentration in young nonobese subjects with low insulin sensitivity
ea0022p345
Microvascular reactivity and oxidative stress after standard breakfast in patients with recently diagnosed type 2 diabetes
ea0022p346
Quantitative and qualitative changes in T regulatory lymphocytes (Tregs) in newly-diagnosed patients with type 1 diabetes
ea0022p347
Vanishing testes syndrome associated with diabetes mellitus
ea0022p348
The high prevalence of abnormal cardiac function in diabetic patients of a developing community
ea0022p349
The GG genotype of the G-11391A ADIPOQ polymorphism might be a risk factor for development of type 2 diabetes mellitus in women
ea0022p350
Increased serum nesfatin-1 levels in patients with impaired glucose tolerance
ea0022p351
TCF7L2 gene variants and polycystic ovary syndrome
ea0022p352
Insulin sensitivity and acute insulin response in pateints with primary hyperparathyroidism before and after surgical treatment
ea0022p353
Renal complications of aldosteronism and diabetes: role of oxidative stress and protective effects of polyphenol extract
ea0022p354
Prediction of incident diabetes mellitus by baseline insulin-like growth factor 1 levels
ea0022p355
Fasting and postprandial effects of rosiglitazone on low- and high-density lipoproteins size and subclasses in type-2 diabetes
ea0022p356
Levels of adrenomedullin during low dose Synacthen test in diabetics type 1
ea0022p357
Antioxidative effect of green tee and red wine polyphenol extracts on RINm5F cells after oxidative stress induction
ea0022p358
Waiting time for emergency renal replacement therapy in patients with end stage renal failure secondary to diabetes mellitus
ea0022p359
Obestatin and ghrelin inhibit apoptosis of human pancreatic islet endothelial cells in high glucose culture
ea0022p360
Hepatic mitochondrial direct effects of thiazolidinediones: pioglitazone and rosiglitazone
ea0022p361
Glycemic control and treatments in adults with type 1 diabetes mellitus
ea0022p362
Diabetic mastopathy: imaging and management
ea0022p363
Evaluating the effects of vitamin D metabolism on glycemic parameters and atherosclerosis markers in prediabetic patients
ea0022p364
Analysis of incidence and risks factors of gestational diabetes in our area: comparison between two periods
ea0022p365
Disease-modifying drugs in the treatment of intermittent claudication in patients with diabetes mellitus: the pilot study
ea0022p366
Evaluation of HbA1c levels for the detection of prediabetes
ea0022p367
Comparative evaluation of serum concentrations of a novel adipocytokine, fibroblast growth factor-21 in patients with type 2 diabetes and obesity
ea0022p368
The importance of the polymorphism of the AT1-receptor gene in diabetic nephropathy patients
ea0022p369
Endocrine Disruptors
Association between ischemia-modified albumin and oxidative stress markers in patients with metabolic syndrome
ea0022p370
Effects of lambda-cyhalothrin on hematological parameters and testicular functions in male rat
ea0022p371
Evaluation of paraxonase activity, malondialdehyde and thiol levels in patients with hypogonadism before and after treatment
ea0022p372
Micronucleus evaluation in mitogen-stimulated lymphocytes of patients with acromegaly
ea0022p373
Paraoxonase is reduced in patients with GH deficiency: a risk factor for atherosclerosis?
ea0022p374
Normal cortisol response to high dose Synacthen and insulin tolerance test in children and adults with Prader--Willi syndrome (PWS)
ea0022p375
Endocrine tumours & neoplasia (
Generously supported by Novartis
)
Biochemical diagnosis strategy in pheochromocytoma
ea0022p376
Carcinoid syndrome: biochemical diagnosis
ea0022p377
Identification of a novel mutation of MEN1 gene in a patient with persisting primary hyperparathyroidism
ea0022p378
No secreting multiple glucagonoma: one case
ea0022p379
RET codon 618 mutations is the most frequent phenotype in Saudi families with multiple endocrine neoplasia type 2A
ea0022p380
CYP24A1 haplotypes are associated with differentiated thyroid carcinoma
ea0022p381
Surgical treatment of insulinomas: a single-institution experience of 48 patients
ea0022p382
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience
ea0022p383
Real-time PCR is useful to detect menin gene deletions
ea0022p384
Role of piuitary tumour transforming gene 1 in medullary thyroid carcinoma
ea0022p385
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability
ea0022p386
GH influences breast cancer chemoresistanec independently of cell cycle perturbations
ea0022p387
Human presentation of MEN X syndrome
ea0022p388
The diagnostic value of PTH concentration in the needle washout after fine-needle biopsy of suspicious cervical foci in patients with hyperparathyroidism
ea0022p389
Sex hormone-binding globulin (SHBG) gene pentanucleotide TAAAA repeat and D327N polymorphism in breast cancer: link to estrogen sensitivity
ea0022p390
Anti-tumor activity of the tumor-vascular-disrupting agent ASA404 (vadimezan) in endocrine tumor models
ea0022p391
Primary hyperparathyroidism and hyperuricaemia and bone turnover
ea0022p392
Bilateral giant myelolipoma of adrenal glands: a case report and review of the literature
ea0022p393
A case of septo-optical dysplasia: are late complications inevitable in spite of early diagnosis and regular follow-up?
ea0022p394
Rare metastases localization in medullary thyroid carcinoma (MTC)
ea0022p395
Outcome of two chemotherapies in the treatment of progressive, undifferentiated neuroendocrine carcinomas: a single-center experience
ea0022p396
Incidence, clinical presentation and outcome of differentiated thyroid cancer in young patients aged 10--24 years living in the French Rhone-Alpes region
ea0022p397
Clinical, hormonal and molecular differences in pituitary ACTH adenomas without (silent corticotroph adenomas) or with Cushing's disease
ea0022p398
Six members of a family with multiple endocrine neoplasia type 2A
ea0022p399
Hepatic transplant and use of radionuclides as adyuvant therapies for patients with metastasic disease from neuroendocrine tumors
ea0022p400
Down-regulation of estrogen receptor-
associates with transcriptional coregulator PATZ1 delocalization in human testicular seminomas
ea0022p401
High prevalence of dopamine excess in patients with head and neck paragangliomas
ea0022p402
Pheochromocytoma: seconds from disaster
ea0022p403
Ectopic insulin secretion from distant metastasis or ectopic metaplasia after total pancreatectomy for ACTH-secreting endocrine pancreatic tumor revealing a Von Hippel Lindau disease
ea0022p404
Cinacalcet hydrochloride effectively controlled primary hyperparathyroidism in patients unresponsive to bisphosphonates
ea0022p405
Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients
ea0022p406
Expression of Ki-67, RET and p53 in papillary thyroid microcarcinomas with or without autoimmune thyroid diseases
ea0022p407
Familial acromegaly
ea0022p408
Paraganglioma in a patient with atrophic gastritis
ea0022p409
Evaluation of respiratory function in acromegalic patient
ea0022p410
Single hospital experience of carcinoid tumours of colon and rectum
ea0022p411
Long-term outcome of 65 patients with metastatic differentiated thyroid carcinoma
ea0022p412
Von Hippel-Lindau disease: a case report
ea0022p413
Natural history and clinical features of metastatic differentiated thyroid carcinoma
ea0022p414
Atypical bronchopulmonary carcinoid tumor metastatic to endocrine glands and bone marrow
ea0022p415
Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma characterized for plasma mitotane level and ERCC1 protein expression analyses
ea0022p416
Rapid activation of cPLA2 induced by oestrogen in ER-positive and ER-negative breast cancer cell lines
ea0022p417
Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?
ea0022p418
Erythropoietin levels in endocrinopathies
ea0022p419
Prolactinoma registry- usefulness of a web tool
ea0022p420
Thyroid Incidentaloma identified by 18F-Fluorodeoxyglucose Positron Emission Tomography with CT (FDG-PET/CT): clinical relevance
ea0022p421
Juvenile hypertension due to coexistence of two very rare etiologies
ea0022p422
Reversible heart failure after sorafenib administration in advanced metastatic differentiated thyroid carcinoma (DTC)
ea0022p423
Serum concentration of o,p'DDD (mitotane), o,p'DDA and o,p'DDE as predictors of tumour response in adrenocortical carcinoma: results of a retrospective European Network for the Study of Adrenal Tumors (ENS@T) multicentre study
ea0022p424
Clinical features and outcome of sporadic medullary thyroid carcinoma
ea0022p425
Adrenocortical carcinoma (ACC): our experience
ea0022p426
Polymorphisms in RET gene are associated with RET/PTC rearrangements in papillary thyroid carcinoma (PTC)
ea0022p427
Malignant paraganglioma - the story of a long time survival
ea0022p428
Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum
ea0022p429
Intronic polymorphism IVS14-24G/A of the RET proto-oncogene seems to be protective for sporadic medullary thyroid carcinoma development
ea0022p430
The Role of miRNA in reduction of type I 5'-iodothyronine deiodinase expression (D1) in renal clear cell carcinoma (ccRCC)
ea0022p431
Unexplained hypoxemia in a patient with carcinoid syndrome
ea0022p432
Pituitary adenoma mimicking a psychiatric disorder - a case report
ea0022p433
Identification of hyperfunctioning parathyroids (HP) in primary hyperparathyroidism (pHPT) in the presence of concomitant thyroid diseases
ea0022p434
Molecular analysis of tumor tissue enabled selection of a successful combined therapy of somatostatin and dopamine agonists in a case of TSH-secreting pituitary adenoma
ea0022p435
Aryl hydrocarbon receptor- interacting protein: mutational analysis and functional validation in primary pituitary cell cultures
ea0022p436
RET mutation screening in multiple endocrine neoplasia type 2 (MEN2) and medullary thyroid carcinoma patients (MTC) in Romania
ea0022p437
Gonadotrophinoma and parathyroid adenoma
ea0022p438
Cushing's syndrome, clinicaly non-functioning pituitary adenoma and hypercalcemia
ea0022p439
Use of recombinant human thyroid-stimulating hormone (rhTSH) in children and adolescents with differentiated thyroid cancer
ea0022p440
Metastatic mammary carcinomas with neuroendocrine features- a case report
ea0022p441
The laterocervical unique masses - a challenging pathology
ea0022p442
Is In2-ghrelin variant, a ghrelin gene derived transcript, a novel player in breast cancer tumors?
ea0022p443
Gastroenteropatic Neuroendocrine tumors: multidisciplinary approach in therapy
ea0022p444
The use of receptor tyrosine kinase inhibitors in metastatic differentiated thyroid carcinoma
ea0022p445
The relationship of testosterone to PSA in men with sexual dysfunction
ea0022p446
Primary carcinoid as an incidental finding in a mature cystic teratoma of the ovary: case report
ea0022p447
Conditions and implications of rhTSH application for ablation in treatment of Differentiated thyroid cancer
ea0022p448
Pheochromocytomas in the RET protooncogene mutations carriers
ea0022p449
Unusual cause of hyercalcemia in pheochromocytoma
ea0022p450
Prokineticin 1 stimulates prostate epithelial cell migration and proliferation in vitro
ea0022p451
Cushing's disease as the first manifestation of familial multiple endocrine neoplasia syndrome type 1
ea0022p452
Two exceptional etiologies of classic endocrinopathies
ea0022p453
Peptide receptor radionuclide therapy and NETs: how to select patients?
ea0022p454
Clinical characteristics of incidentally discovered phaeochromocytomas
ea0022p455
The clonidine supression test with measurement of plasma metanephrines by enzyme immunoassay
ea0022p456
Supradiaphragmatic ectopic ACTH: producing pituitary adenoma: a case report
ea0022p457
Female reproduction
GnRH test as an additional investigation in the diagnosis of polycystic ovary syndrome (PCOS): potential application of stimulated LH/FSH ratio
ea0022p458
CAG repeat polymorphism in women with PCOS and healthy controls
ea0022p459
CAG repeat polymorphism in healthy women
ea0022p460
Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women
ea0022p461
The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy postmenopausal women
ea0022p462
Ethnic differences in manifestations of PCOS in 1010 Danish women
ea0022p463
Kisspeptin levels in high risk pregnancies related to chronic diseases: insulin dependent diabetes mellitus (IDDM) and arterial hypertension (H)
ea0022p464
Role of vitamin D treatment on metabolic and endocrine parameters in PCOS women
ea0022p465
Serum soluble transferrin receptor (sTfR) concentrations and sTfR/ferritin ratio in premenopausal women: associations with glucose tolerance, insulin sensitivity and androgen excess
ea0022p466
Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
ea0022p467
Familial occurrence of hormonal and metabolic abnormalities in first-degree relatives of women with PCOS
ea0022p468
Chronic inflammation and Leu55Met PON1 polymorphism in polycystic ovary syndrome
ea0022p469
Serum vaspin levels in women with polycystic ovaries and polycystic ovary syndrome
ea0022p470
Characteristics secretion of melatonin at women with polycystic ovary syndrome
ea0022p471
HPA axis function in obese women with PCOS
ea0022p472
Metabolic syndrome indices and Framingham risk scoring in women with polycystic ovary syndrome
ea0022p473
Serum ferritin in female-to-male transsexuals with polycystic ovary syndrome
ea0022p474
Endothelial structure and function in young women with polycystic ovary syndrome: a 5 years follow-up study
ea0022p475
Structured exercise training plus hypocaloric diet improves ovarian sensitivity to clomiphene citrate in polycystic ovary syndrome (PCOS) patients
ea0022p476
An association between autoimmune thyroiditis and premature ovarian failure: a cross-sectional study
ea0022p477
The polymorphic Alu1 variant of ER
may modulate the feedback regulation of LH secretion
ea0022p478
Expression of StAR protein and steroidogenic enzyme mRNAs in ovarian follicles of the domestic hen (Gallus gallus domesticus)
ea0022p479
Endocrine safety of ulipristal acetate, a selective progesterone receptor modulator (SPRM): results from two phase II randomised, placebo-controlled studies
ea0022p480
Serum concentrations of carboxylated osteocalcin are increased and associated with the components of the polycystic ovarian syndrome
ea0022p481
Ascending aortic dilatation in Turner syndrome: the natural history
ea0022p482
AMH secretion seems not to be influenced by acute GnRH-analogue administration in PCOS patients
ea0022p483
Metabolic changes associated with hypogonadotropic hypogonadism in women of reproductive age and effect of HRT
ea0022p484
The ovulatory capacity and related genes are altered in transgenic mice hypersecreting human chorionic gonadotrophin hormone (hCG)
ea0022p485
The prevalence and phenotypes of polycystic ovary syndrome in Korean women
ea0022p486
Hormonal correlates of different ejaculatory latencies in subjects with sexual dysfunction
ea0022p487
Cardiovascular risk in lean algerian PCOS
ea0022p488
Polymorphisms in the estrogen receptor
gene and reproductive axis in women
ea0022p489
Spontaneous pregnancy in Sheehan syndrome
ea0022p490
Sheehan syndrome: metabolic and hormonal abnormalities (46 cases)
ea0022p491
Progesterone receptor signaling: new tricks from an old dog
ea0022p492
Inflammatory markers, adiponectin and metabolic characteristics in different phenotypes of polycystic ovary syndrome
ea0022p493
Vitamin D levels in pregnant women in the city of Burgos (Spain)
ea0022p494
The role of hyperprolactinemia in periductal and intraductal inflammation in mammary gland
ea0022p495
The impact of the disease on life quality and health concept in young women with Turner's syndrome
ea0022p496
The value of ovarian reserve markers in assisted reproductive technology
ea0022p497
CAG repeat alleles of the androgen receptor are associated with polycystic ovary syndrome (PCOS) in the Romanian population
ea0022p498
The unfavourable effect of oral contraceptive pills on the metabolic parameters in women with polycystic ovary syndrome
ea0022p499
The effects of metformin therapy on hirsutism, androgen and metabolic parameters in PCOS women
ea0022p500
Some subordinate steroid metabolites may better predict gestational age than the main pregnancy steroids
ea0022p501
Growth factors
Ghrelin (hunger hormone) and its effects on GH mean plasma concentration with different energy levels in camel
ea0022p502
Acromegaly: a prospective analysis of the oral and maxillofacial pathologies and its impact of disease duration
ea0022p503
Designing a long acting human GH by fusing the carboxyl-terminal peptide of human chorionic gonadotropin [beta] subunit to the coding sequence of human GH
ea0022p504
Serum IGF1 levels in adult patients with type 1 Gaucher disease
ea0022p505
Testicular TGF-[beta]1 system expression and its participation in hypertrophy and hyperplasia of Leydig cells
ea0022p506
GH modulates migration of developing T cells
ea0022p507
Insulin resistance induced by GH is transient and reversible: glucose clamp studies during different ambient GH levels in GH-deficient adults
ea0022p508
Two years of GH therapy improves body composition in adults with Prader-Willi Syndrome
ea0022p509
Growth failure in a girl harbouring digenic heterozygote mutations in the Ferroportin1-gene and the HFE-gene
ea0022p510
IGF1 and IGFBP3 levels in relapsing-remitting and secondary progressive multiple sclerosis (MP)
ea0022p511
Decreased expression of apoptotic genes in skeletal muscles, but not in hearts, of GH receptor knockout (GHRKO) mice
ea0022p512
Overexpression of mRNA IGF1R during apoptosis in mice hepatic and cardiac cells
ea0022p513
Statin modulation of growth factors in piglets with metabolic syndrome
ea0022p514
Formation of neutralizing anti-human GH (hGH) antibodies does not explain the lack of IGF1 increase after recombinant hGH treatment in mice
ea0022p515
The role of fibroblast grow factor 23 in vascular calcification
ea0022p516
Male reproduction
Gonadotrophins level in azoospermic patients in Plateau State
ea0022p517
The case for comprehensive medical testing of gamete donors
ea0022p518
Exogenous gangliosides modulate cellular free radical production
ea0022p519
Regulation of sperm EGFR by ouabain leads to initiation of the acrosome reaction
ea0022p520
Effect of melatonin in the phosphorylation of ERK42/44, P38 and JNK46/54, and the expression of c-jun and c-fos in hamster Leydig cells
ea0022p521
Effect of prolactin (PRL) and melatonin (Mel) in the regulation of cyclooxygenase 2 (COX2) expression in Syrian hamster Leydig cells
ea0022p522
The Moscow Study: a randomized, placebo-controlled, double-blind trial of parenteral testosterone undecanoate on the prostate status and blood count
ea0022p523
Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome: the Moscow Study
ea0022p524
Total but not calculated free testosterone concentration is lowered in young healthy South Asian men
ea0022p525
Effects of atorvastatin on male fertility
ea0022p526
Tadalafil attenuates proliferation and transdifferentiation of prostatic stromal cells indicating therapeutic potential for benign prostatic hyperplasia
ea0022p527
Single nucleotide polymorphism (SNP) of endothelial nitric oxide synthase (eNOS) gene (GLU298ASP VARIANT) in infertile men with asthenozoospermia
ea0022p528
Infertility and low gonadotropin levels as the first sign of testicular seminoma: a case report
ea0022p529
Congenital hypogonadotropic hypogonadism in men as a cause of estradiol deficiency
ea0022p530
Prevalence and characterization of hypogonadism among men with human immunodeficiency virus infection: preliminary results
ea0022p531
Validation of salivary testosterone as a diagnostic test in the hypothalamic-pituitary-gonadal axis diseases
ea0022p532
Determination of the reference values of total testosterone, calculated free testosterone, calculated bioavailable testosterone and salivary testosterone in young, healthy population of the Mediterranean area
ea0022p533
Blood pressure control and endothelial funtion in type 2 diabetes: importance of nutritional educational program
ea0022p534
Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome
ea0022p535
Sexual dysfunctions in subjects with Klinefelter's syndrome
ea0022p536
A case of partial androgen insensitivity syndrome with absence of breast development
ea0022p537
Sexual and gonadal function in men after cardiac transplantation
ea0022p538
Partial androgen insensitivity may be the reason for impaired fertility in men with Noonan Syndrome
ea0022p539
Can high radioactive contamination possibly influence frequency of androgen receptor mutation?
ea0022p540
The effect of undecanoat testosterone depot on the prostate volume
ea0022p541
Initial characterization of the human seminal plasma proteome in a fertile normogonadic man by top-down strategy
ea0022p542
Serum INSL3 dynamics in young men with congenital hypogonadotropic hypogonadism treated with gonadotropins
ea0022p543
Testosterone replacement therapy isn't always contraindicated after prostate cancer treatment: case report
ea0022p544
Neuroendocrinology and Pituitary (
Generously supported by Novartis
)
Prothrombin time, activated thromboplastin time, fibrinogen, and D-dimer levels, and von Willebrand activity of patients with Sheehan's syndrome and the effect of hormone replacement therapy
ea0022p545
Plasma agouti-related peptide (AgRP) levels in male patients with hypogonadotropic hypogonadism
ea0022p546
Ghrelin and leptin levels in acromegalic patients treated with pegvisomant
ea0022p547
Evaluation of adrenal morphological and functional alterations in acromegalic patients
ea0022p548
IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly
ea0022p549
Angiotensin converting enzyme I/D and M235T angiotensinogen gene polymorphism in patients with acromegaly
ea0022p550
Combined endoscopic and pharmacologic treatment of a suprasellar arachnoid cyst associated with macroprolactinoma
ea0022p551
Incidentally found nonfunctioning pituitary macroadenomas: should we suspect them earlier?
ea0022p552
Efficacy of acromegaly treatment in six Czech and Slovak tertiary centers: first analysis of patient registry RESET (Registry of Sellar Tumors)
ea0022p553
Increased prevalence of psychopathology and maladaptive personality traits in patients after long-term cure of Cushing's disease
ea0022p554
Negative magnetic resonance imaging in Cushing's disease
ea0022p555
Development of a new questionnaire for evaluating QOL in adult hypopituitarism: adult hypopituitarism questionnaire (AHQ)
ea0022p556
Plasma ghrelin concentrations in narcoleptic patients
ea0022p557
Clinically silent pituitary macroadenomas: a clinicopathologic analysis
ea0022p558
Hormonal and non-hormonal factors contributing to chronic fatigue in traumatic brain injury patients
ea0022p559
Management of patients with childhood onset GH deficiency (COGHD) in the transition phase
ea0022p560
The diagnosis of GH deficiency in obese patients: what help from pharmacological blockade of lipolysis?
ea0022p561
Assessment of biochemical control of acromegaly during treatment with somatostatin analogues: is there still a role for glucose oral load?
ea0022p562
Influence of psychological variables on partially and fully recovering in patients with anorexia nervosa
ea0022p563
Use of cabergolin in Nelson's syndrome: preliminary results in four patients
ea0022p564
Daily temozolomide therapy in Nelson's syndrome
ea0022p565
Euthyroidism and tumor stability achieved in a TSH-secreting pituitary macroadenoma treated with octreotide-LAR and cabergoline: case report and literature review
ea0022p566
Effects of GH replacement therapy on hematopoiesis and immune function: a placebo controlled study
ea0022p567
Comparison of 1 [mu]g ACTH, 250 [mu]g ACTH and glucagon tests for assessment of the hypothalamo-pituitary-adrenal axis in healthy subjects
ea0022p568
Unsatisfied treatment outcomes of acromegaly patients: a single center experience in Turkey
ea0022p569
The presentation of sellar and parasellar tumours in Uzbekistan
ea0022p570
Long-term morbidities in patients with Cushing's disease
ea0022p571
Comparison of different therapy approaches in acromegaly
ea0022p572
Clinical and epidemiologic features of acromegaly in the Republic of Uzbekistan
ea0022p573
Frequency of neuroendocrinal disturbances in patients with different pituitary adenomas
ea0022p574
Frequency of a postoperational hypopituitarism in patients with pituitary tumors after transnasal hypophysectomies
ea0022p575
Manifestation factors of the disease and complications rate in patients with acromegaly from Aral Sea regions of the Republic of Uzbekistan
ea0022p576
Pneumocystis pneumonia during conservative treatment of Cushing's syndrome: description of two cases
ea0022p577
Use of the desmopressin test in the differential diagnosis of Pseudo-Cushing state from Cushing's disease
ea0022p578
The prognostic criteria for the efficiency of the long-termed administration of somatostatin analogues
ea0022p579
Incidence and dynamics of visual disturbances in hypothalamus and pituitary mass lesions after transphenoidal surgery in the Republic of Uzbekistan
ea0022p580
The rate of vascular complications in acromegaly in the Republic of Uzbekistan
ea0022p581
Long and short-term therapy effectiveness with dopamine agonists in acromegaly in the Republic of Uzbekistan
ea0022p582
Plasma asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine and arginine levels in patients with active acromegaly
ea0022p583
Heparanase is highly expressed in GH-adenomas and regulates proliferation of pituitary tumor cells
ea0022p584
The metabolic syndrome (MetS) in 2610 GH deficient (GHD) subjects before GH replacement: a KIMS (Pfizer International Metabolic Database) analysis
ea0022p585
Effect of octreotide LAR on the volume of pituitary adenoma in acromegalic patients
ea0022p586
Evaluation of efficacy of somatostatin analogue octreotide LAR in acromegalic patients following non-radical surgery of pituitary adenoma
ea0022p587
Prospective evaluation of traumatic brain injury mediated hypopituitarism 1 year after the event
ea0022p588
The influence of the successful treatment of acromegaly on tissue distribution and overall BMD
ea0022p589
Sleeping apnea syndrome (SAS) in acromegaly and obesity
ea0022p590
The effect of gonadal replacement on insulin resistance in hypogonadal adult men with GH deficiency
ea0022p591
The anorexigenic neuropeptide, NUCB2/nesfatin-1, is indispensable for normal puberty onset in the female rat
ea0022p592
Investigation of skin characteristics in patients with acromegaly
ea0022p593
Efficacy and safety of combined treatment with somatostatin analogues (SA) AND pegvisomant (PEG) in acromegalic patients resistant to SA
ea0022p594
Pituitary functions in patients with chronic subdural hematoma
ea0022p595
Comparison of the efficacy of GH therapy in short children with decreased nocturnal GH secretion and either normal or subnormal results of GH stimulating tests
ea0022p596
Contribution of the molecular biology to the study of the behaviour of pituitary adenomas
ea0022p597
The occurrence of hypothyroidism during the initial phase of GH replacement therapy in children with GH deficiency: clinical implications
ea0022p598
The prothrombotic state in patients with Cushing's disease
ea0022p599
Usefulness of cabergoline determination by mass spectrometry during prolactinoma treatment
ea0022p600
Basal and stimulated GH secretion in Cushing's syndrome: effects of ghrelin and GHRH+arginine
ea0022p601
Application of the human chorionic gonadotropin immunoassay in cerebrospinal fluid for the diagnostic work-up of neurohypophyseal germinomas
ea0022p602
Adrenalectomy (ADX) increases the activation of hypothalamic and nucleus of the solitary tract (NTS) neurons related with food intake control during endotoxemia
ea0022p603
CB1 modulation of hormone secretion, neuronal activation and mRNA expression following blood volume expansion (BVE)
ea0022p604
The regulation of the hypothalamic-pituitary axis is altered in transgenic male mice overexpressing human chorionic gonadotrophin (hCG)
ea0022p605
Impact of rosiglitazone on serum IGF1 concentrations in uncontrolled acromegalic patients under conventional medical therapy: results from a pilot phase 2 study
ea0022p606
Quality of life after multimodality treatment of acromegaly
ea0022p607
Epidemiology and outcomes after multimodality therapy of acromegaly over three decades in the Maltese population
ea0022p608
An adult patient with ectopic neurohypophysitis and panhypopituitarism due to absent pituitary stalk
ea0022p609
Presentation, treatment and outcomes in patients with non-functioning pituitary adenomas (NFPA) in Malta
ea0022p610
Plasma levels of adiponectine and nutritional status in patients affected by anorexia Nervosa
ea0022p611
The predictors of the response to somatostatin analogue therapy in patients with acromegaly
ea0022p612
Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma
ea0022p613
Risk factors for development of atherosclerosis in young women with hyperprolatinemia
ea0022p614
Lanreotide-ATG effectiveness on tumoral mass shrinkage of two thyrotropin-secreting pituitary macroadenomas
ea0022p615
Pain characteristics in patients with Cushing's disease compared to patients with non-functioning pituitary adenomas
ea0022p616
Epidemiology of craniopharyngioma in Denmark 1985-2004: a 2% increase in incidence rate per year
ea0022p617
Long term safety of recombinant human growth hormone (rhGH) in patients treated during childhood
ea0022p618
Lymphocytic hypophysitis: clinical characteristics and endocrine features of 64 GH deficient patients in KIMS: Pfizer International Metabolic Database
ea0022p619
Epidemiology of acromegaly in Italy
ea0022p620
Decreased cortical thickness on MRI in patients with Cushing's syndrome: preliminary experience
ea0022p621
Patients with prolactinomas exhibit distinct personality patterns: comparison of 84 prolactinoma patients with 58 patients with non-functioning pituitary adenomas and 168 age- and gender-matched controls
ea0022p622
Circadian rhythmicity changes of gonadal and growth axis in adolescent idiopathic scoliosis
ea0022p623
Ultrasound-assisted microsurgery for pituitary macroadenomas
ea0022p624
Efficacy and safety of co-administration of lanreotide Autogel 120 mg monthly with pegvisomant weekly in patients with acromegaly partially controlled by somatostatin analogues
ea0022p625
Longitudinal combined evaluation of antipituitary antibody titer and immunofluorescence pattern is a suitable tool in predicting autoimmune hypophysitis in patients with autoimmune polyendocrine syndromes
ea0022p626
Pituitary surgery for Cushing's disease: the use of per-operative ACTH sampling
ea0022p627
Evaluation of the relationship between macroprolactin levels and clinical and radiological findings in patients with hyperprolactinemia
ea0022p628
Flexion contractures syndrome as the initial manifestation of hypopiptuitarism
ea0022p629
Outcome of patients with diabetes insipidus associated with adipsia
ea0022p630
Correlation between GH and FSH in the cerebrospinal fluid and sleep respiratory events
ea0022p631
Modification of epicardial fat thickness in adult GHD patients after short-term replacement therapy with rhGH
ea0022p632
Relationship between metabolic parameters and central dopaminergic activity in healthy men
ea0022p633
Results of French collaborative evaluation (DEPHY-TC) in patients with suspected pituitary abnormalities after traumatic brain injury (TBI)
ea0022p634
A case of lymphocytic panhypophysitis
ea0022p635
Evaluation of quality of life in patients with acromegaly using the acromegaly quality of life questionnaire (AcroQoL)
ea0022p636
Rapid bone loss 23 years after diagnosis for childhood acute lymfoblastic leukaemia (ALL) in spite of GH therapy
ea0022p637
Effects on glucose metabolism of high-dose octreotide LAR in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
ea0022p638
Sub-acute tumour debulking with somatostatin analogues in newly diagnosed acromegaly due to macroadenomas
ea0022p639
Long-term treatment of Cushing's disease with pasireotide (SOM230): results from a Phase II extension study
ea0022p640
Heterogeneous origin of idiopathic isolated central hypothyroidism
ea0022p641
Echocardiographic assessment of cardiac valves morphology and function in patients with prolactinomas under long-term treatment with cabergoline or bromocriptine
ea0022p642
The effect of GH on rat neurogenesis in the dentate gyrus of hypocampus
ea0022p643
Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study
ea0022p644
Long-term treatment of acromegaly with pasireotide (SOM230): results from a Phase II extension study
ea0022p645
Growth modelling of non-functioning pituitary adenomas
ea0022p646
A case of empty sella turcica and Cushing's disease
ea0022p647
Reproductive changes in females with 'empty sella' syndrome
ea0022p648
Aftercare in patients with Cushing's disease and acromegaly: is there room for improvement?
ea0022p649
Persistent hypocortisolism in Cushing's disease and persistent comorbidities in acromegaly determine neurocognitive function and quality of life after surgical treatment
ea0022p650
Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegaly
ea0022p651
A case of giant prolactinoma in a 14-year old boy
ea0022p652
Leptin receptor gene expression and its promoter methylation do not change with age in peripheral blood mononuclear cells
ea0022p653
Presence of kiss1/kiss1r system at the pituitary, testis and adipose tissue in rodents: functional actions and regulation by physiological cues
ea0022p654
Kisspeptin selectively increases LH and GH, but not FSH, ACTH, PRL or TSH, release in primary pituitary cell cultures from a non-human primate (Papio anubis) via distinct signaling pathways and under influence of sex steroids
ea0022p655
Diabetes Mellitus influence on GH and IGF-1 levels in acromegalic patients
ea0022p656
Cabergoline treatment in Cushing's disease: effect of cabergoline withdrawal in patients with normalized cortisol secretion after long-term treatment
ea0022p657
Carbohydrate disorders in patients with acromegaly
ea0022p658
Study of pituitary function in acromegaloidism
ea0022p659
Trends in acromegaly treatment in Spain
ea0022p660
SSTR5 ligand binding domain immunohistological detection in pituitary adenomas using Y-SSTR5 a new mouse monoclonal antibody
ea0022p661
Acromegaloidism: description of fifteen cases
ea0022p662
Sellar lesions in Ollier disease: case report and a review of the literature
ea0022p663
Comparison of efficacy of cabergoline and bromocriptine retrospectively in patients with hyperprolactinemia
ea0022p664
Transition from Cushing's disease to a hormonally inactive adenoma or vice versa: four unusual cases of corticotroph adenoma
ea0022p665
comparison of octreotide LAR and lanreotide autogel treatments in post-operative medical treatment of acromegaly
ea0022p666
FSH-staining pituitary adenomas: a review of 37 cases
ea0022p667
IGF1 levels as predictor factor of metabolic derangement in adult patients with severe GH deficiency
ea0022p668
Hypertension as the first and for long time period the only sign of ACTH producing pituitary adenoma: A case report
ea0022p669
Obesity
Impact of sarcopenia on metabolic profile in sarcopenic-obese post menopausal women?
ea0022p670
Metabolic surgery (gastric bypass) has no 'magical effect' in severely obese patients with type 1 diabetes
ea0022p671
Testosterone gel significantly increase lean body mass in ageing males with relatively low bio-available testosterone and waist circumference above 94 cm: a double blinded, randomized, placebo controlled 6 months study
ea0022p672
Ghrelin basal levels in people with abdominal obesity
ea0022p673
Osteocalcin and the metabolic syndrome
ea0022p674
Relationship between obesity and classic cardiovascular risk factors
ea0022p675
Pathological types of the family education as the risk factor of the childhood obesity
ea0022p676
TSH levels in overweight and obese euthyroid subjects with metabolic syndrome
ea0022p677
Complementary and alternative treatment approaches in obese patients: a cross-sectional study
ea0022p678
Differential expression of proteins in omental and subcutaneous adipose tissue
ea0022p679
Relationship between the breast cancer and abdominal obesity
ea0022p680
The Moscow study: a randomized, placebo-controlled, double-blind trial of parenteral testosterone undecanoate on the metabolic syndrome components and body composition
ea0022p681
Effects of parenteral testosterone undecanoate administration on inflammatory markers: the Moscow study
ea0022p682
Visceral fat accumulation as a risk factor for the carotid plaque occurrence in ischemic stroke patients
ea0022p683
Relation of PPAR[gamma] genetic polymorphism and testosterone levels in males with metabolic syndrome
ea0022p684
The effects of orlistat on weight, serum lipids, blood pressure and fasting plasma glucose in obese patients with prediabetes
ea0022p685
Increased oxidative damage to lipids and DNA in overweight and obese patients
ea0022p686
Glucagon stimulates cholecystokinin secretion in humans
ea0022p687
Early genetic rescue of extremely obese POMC-deficient mice is critical for successful recovery of normal feeding behavior and body weight
ea0022p688
Influence of age of onset of metabolic syndrome
ea0022p689
Serum fibroblast growth factor 21 in human obesity: regulation by hyperinsulinemia and relationship with glucose and lipid oxidation
ea0022p690
Predictive factors for a good response to antidepressant pharmacotherapy in patients with metabolic syndrome
ea0022p691
Assessment of correlations between IL-18, CRP and selected adrenal androgens serum levels according to the anthropometrical and biochemical indices of metabolic syndrome (MS) in ageing men
ea0022p692
The obese phenotype is associated with more severe autoimmune thyroiditis evolving towards primary hypothyroidism
ea0022p693
Reference interval values of four plasmatic endocannabinoids measured by isotopic dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)
ea0022p694
The metabolic syndrome and the non-alcoholic fatty liver disease: metabolic and pathology aspects
ea0022p695
Obesogenic environmental risk factors in Belarusian preschool children
ea0022p696
Waist circumference does not reflect body fat distribution and insulin resistance in young male patients with idiopathic hypogonadotrophic hypogonadism
ea0022p697
Abdominal fat, insulin sensitivity, inflammatory atheromatosis risk factors and polymorphisms of 174-G/C IL-6 promoter and Pro12Ala PPAR[gamma] in non-obese subjects
ea0022p698
FTO gene haplotypes are associated with GH levels in lean women
ea0022p699
Obesity and malnutrition are associated with different inflammation patterns in rats
ea0022p700
The circulating pattern of adiponectin and resistin in critically ill patients with sepsis
ea0022p701
Acylated, unacylated ghrelin and obestatin regulation during oral glucose tolerance test in obese prepubertal and pubertal children
ea0022p702
Melanocortin-4 receptor gene polymorphism (rs12970134) influences glucose metabolism, leptin and GH levels in women
ea0022p703
Vitamin D levels in obese patients with and without metabolic syndrome
ea0022p704
Relation of waist line radius and subcutaneous adipose tissue thickness positively correlates with markers of impaired glycemic control
ea0022p705
The influence of weight-loss induced by bariatric surgery on serum concentrations of novel metabolic regulators FGF-21 and FGF-19 in morbidly obese subjects
ea0022p706
Complementary and alternative medicine use in patients with obesity: an anthropological approach
ea0022p707
Prevalence of no insulin-resistance in morbidly obese patients
ea0022p708
Influence of metformin therapy on peripheral blood androgenes concentrations in young women with metabolic syndrome
ea0022p709
Sideways in treatment of obese child: a personal experience
ea0022p710
Limited weight loss with gastric banding in patients with craniopharyngeoma
ea0022p711
Desacyl-ghrelin as a protective factor for obesity
ea0022p712
Gastric inhibitory polypeptide (GIP) suppresses circulating ghrelin in humans: plasma metabolome based correlation network analysis for support of hormone-to- hormone interactions
ea0022p713
Effects of breastfeeding on maternal appetite-regulating hormones
ea0022p714
Relation of weight, height and BMI of child to parental characteristics in families with obese or overweight parents before weight management: diogenes project
ea0022p715
Childhood obesity surveillance initiative in the Czech Republic: the association between BMI and school environment
ea0022p716
Characterisation of serum and glucocorticoid-induced kinase 1 in adipose tissue
ea0022p717
Carbohydrate metabolism in obese women: association with the circulating levels of adiponectin and retinol binding protein-4
ea0022p718
Lindaxa effectiveness in obesity treatment associated with IGT and arterial hypertension
ea0022p719
Signal transduction
Role of filamin-A in the regulation of dopamine D2 receptor localization and signaling in a lactotroph cell model
ea0022p720
Lysyl oxidase interacts with AGEs signaling to modulate collagen synthesis in polycystic ovarian tissue
ea0022p721
Peroxisome-proliferator-activated receptor gamma is required for modulating endothelial inflammatory response through a novel nongenomic mechanism
ea0022p722
The
subunits of heterotrimeric G-protein in thyroid plasma membranes
ea0022p723
Spatial and temporal regulations of MAPKinases ERK1/2 in the somatolactotroph cell line GH4C1
ea0022p724
Molecular origin of idiopathic central hypogonadism: variable impairment of two signal-transduction pathways due to PROKR2 mutations
ea0022p725
Steroid metabolism & action
Rapid non-genomic effects of cortisol on glucose-induced insulin secretion in humans
ea0022p726
The response of creatine kinase specific activity in rat pituitary to estrogenic compounds and vitamin D less- calcemic analogs
ea0022p727
Association of vitamin D status with serum androgen levels in men
ea0022p728
Testosterone levels in acute exacerbation of chronic obstructive pulmonary disease: relationship with severity indices
ea0022p729
Prospective association of low total testosterone levels with adverse lipid profile and incident dyslipidemia: results from the study of health in Pomerania
ea0022p730
The relationship between aortic stiffness and left ventricular function in patients with Cushing's disease
ea0022p731
Influence of steroid hormones on anthropometric parameters in men
ea0022p732
Aldosterone-induced epithelial sodium channel (ENaC) expression and trafficking is regulated by protein kinase D1 in M1 renal cortical collecting duct cells
ea0022p733
Muscle fiber conduction slowing and decreased levels of circulating muscle proteins after short-term dexamethasone administration in healthy subjects
ea0022p734
Effect of body mass index on differences of sex hormone levels in postmenopausal women receiving low-dose hormone therapy
ea0022p735
Measurement of testosterone in muscle tissue using microdialysis: preliminary data
ea0022p736
Expression and biological function of sex steroid receptors in male human bladder
ea0022p737
Androgenicity is enhanced in the presence of ala222val polymorphism in healthy postmenopausal women
ea0022p738
Synthesis of 1,25-dihydroxyvitamin D in human bladder epithelial cells and vitamin D mediated cathelicidin induction
ea0022p739
Simultaneous steroid measurement by isotopic dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS): comparison with routine analysis methods and reference intervals in normal subjects
ea0022p740
Sex specific association between estrogen receptor alpha PvuII and XbaI gene polymorphisms and hormones
ea0022p741
Tissue expression of the CYP19A1 gene and aromatase protein in male cynomolgus monkeys (Macaca fascicularis)
ea0022p742
Levels of 7-hydroxy DHEA derivates during menstrual cycle
ea0022p743
Sex steroid status in relation to birth weight and body composition in young healthy men
ea0022p744
Thyroid
Effectiveness of consevator treatment (antithyroidiennes and thyroxine) on the autonomous nodule, toxic adenoma, and Plummer's disease (multinodular hyperthyroideous Goiter)
ea0022p745
Pheochromocytoma, papillary thyroid carcinoma: new entity
ea0022p746
Outcome of pregnancy complicated by thyroid dysfunction in Iran
ea0022p747
Detection of BRAF gene mutation in preoperative diagnostic of thyroid gland cancer
ea0022p748
Evaluation of diagnostic utility of Galectin-3 protein detection in preoperative diagnostic of high-differentiated thyroid gland cancer by flow cytometry method
ea0022p749
Promoter methylation of gelsolin gene in thyroid cancer
ea0022p750
Role of hypothyroidism in predicting a worse prognosis of heart failure outpatients treated with amiodarone
ea0022p751
Results from an observational study on general practitioners' and endocrinologists' medic